UNSPSC 51291709: Bipenamol

This classification denotes a serotonin agonist with the molecular formula C14H15NOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49DCB7156W, chemically known as [2-[2-(aminomethyl)phenyl]sulfanylphenyl]methanol but generally known as cericlamine, which bears US NIH Compound Identifier 43961. European Medicines Agency schedules Bipenamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05842MIG.

The term BIPENAMOL is an International Non-Proprietary Name (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25.) Most nations schedule bipenamol under HS 29309085 and SITC 51549. As of Q4 2014, BIPENAMOL remains the US FDA Preferred Term for this commodity. Bipenamol bears US NLM identifiers UMLS ID C2698511 and NCI Concept Code C79854. SMILES: C1=CC=C(C(=C1)CN)SC2=CC=CC=C2CO.

UNSPSC 51291709 Bipenamol is a Commodity code that in state and local practice encompasses pharmaceutical products and drug-related supplies procured for public health and community safety initiatives. The recent solicitation activity shows state and local governments using this code to acquire naloxone and drug deactivation systems rather than bipenamol specifically, indicating that the code functions as a catch-all for emergency pharmaceutical and harm-reduction supplies tied to opioid response and substance-abuse mitigation. Issuing bodies for these procurements include county health departments and public health agencies; the Seminole County, Florida procurement represents the mix of mid-sized jurisdictions pursuing these acquisitions through standard competitive processes.

Seminole County, Florida represents the primary documented activity under this code in the recent opportunities block. The county issued IFB 60459723LAS on June 30, 2026 (though the embedded notice dates reference July 2023, suggesting a reposted or recurring solicitation), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB required electronic submission by July 26, 2023 at 2:00 pm and mandated vendors to include all shipping and delivery costs in their bids; the initial contract term was two years with an optional one-year renewal, and vendors had to comply with E-Verify, drug-free workplace certification, and specific insurance requirements including commercial general liability and professional liability coverage. No geographic concentration beyond Florida or issuing-body concentration beyond county health departments is evident from the available recent opportunities.